Show simple item record

dc.contributor.authorYousaf, Nen_US
dc.contributor.authorGould, Den_US
dc.date.accessioned2017-09-29T16:10:53Z
dc.date.issued2017en_US
dc.date.submitted2017-09-01T13:56:05.381Z
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/26027
dc.description.abstractConstitutive gene expression is not always the appropriate expression system because the unphysiological levels of expressed protein could be detrimental in studies examining biological roles of proteins, or continued expression may be unnecessary after therapeutic effects have been achieved in gene therapy . We have utilized pharmacologically regulated gene expression systems to achieve fine control of gene expression levels which facilitate research in basic biology and translates to use in experimental gene therapy studies. In this chapter, we outline the application of a tightly controlled tetracycline responsive gene expression system.en_US
dc.format.extent159 - 172en_US
dc.language.isoenen_US
dc.subjectCell transfectionen_US
dc.subjectGene expressionen_US
dc.subjectLuciferase assayen_US
dc.subjectPharmacologicalen_US
dc.subjectTetracycline-inducible systemen_US
dc.subjectWestern blotti ngen_US
dc.subjectBlotting, Westernen_US
dc.subjectCell Lineen_US
dc.subjectGene Expression Regulationen_US
dc.subjectGenetic Vectorsen_US
dc.subjectHumansen_US
dc.subjectPromoter Regions, Geneticen_US
dc.subjectReceptors, Tumor Necrosis Factor, Type Ien_US
dc.subjectTetracyclineen_US
dc.subjectTransfectionen_US
dc.titleThe Tetracycline Responsive System.en_US
dc.typeBook
dc.rights.holder© Springer Science+Business Media LLC 2017
dc.identifier.doi10.1007/978-1-4939-7223-4_12en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/28801906en_US
pubs.notesNot knownen_US
pubs.notesThis is the submitted version of the chapteren_US
pubs.publication-statusPublisheden_US
pubs.volume1651en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record